Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-004226
Filing Date
2025-02-14
Accepted
2025-02-14 18:04:58
Documents
1
Period of Report
2025-02-14

Document Format Files

Seq Description Document Type Size
1 form4-02142025_110254.html 4  
1 form4-02142025_110254.xml 4 4238
  Complete submission text file 0001415889-25-004226.txt   5690
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SENSEI BIOTHERAPEUTICS, INC. 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address
Craver Josiah (Reporting) CIK: 0002038400 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39980 | Film No.: 25631535